Information Provided By:
Fly News Breaks for January 29, 2018
LH
Jan 29, 2018 | 06:58 EDT
Goldman analyst Patrick Donnelly assumed coverage on LabCorp with a Conviction Buy, rating Neutral, with a $205 price target telling investors shares are undervalued as growth is set to inflect back to market growth in 2018. Donnelly expects LabCorp to navigate Medicare pricing headwinds and said there is strong underlying volume growth and tax tailwinds not currently reflected in Street estimates, leading to attractive valuation.
News For LH From the Last 2 Days
There are no results for your query LH